A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

Though TB remains the world's top infectious disease killer, there's cause for hope, Fred Hutch Cancer Center experts say.

Ovarian cancer, often referred to as the “silent killer,” is emerging as a serious health concern among women in Jammu and ...

A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered ...

The field of cancer immunology has seen significant advancements in recent years, particularly with the emergence of immunotherapy as a key pillar in the ...

ImmunityBio Inc. (NASDAQ:IBRX)  is one of the best NASDAQ stocks under $30 to buy. On March 17, ImmunityBio announced that ...

Colorectal cancer is now the leading cause of cancer-related death among people under 50, according to the American Cancer ...

News, features, and commentary about cancer-related issues ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Developing the system required careful fine-tuning. Too much stimulation can wear out immune cells, while too little allows ...

A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.

T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.